WHO ICTRP trial
Drugs for LMA insertion
CTRI/2022/02/040264 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/02/040264 |
|---|---|
| Public title | Drugs for LMA insertion |
| Scientific title | COMPARISON OF PROPOFOL VERSUS PROPOFOL WITH LOW DOSE SCOLINE TO EVALUATE LMA INSERTION |
| Primary sponsor | Meenakshi Medical College and Hospital |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: K353- Acute appendicitis with localizedperitonitis Health Condition 2: D369- Benign neoplasm, unspecified site Health Condition 3: N29- Other disorders of kidney and ureter in diseases classified elsewhere Health… |
| Interventions | Intervention1: PROPOFOL: Dose-2.5 mg/kg Route- Intravenous Induce over a period of 30seconds, Repeat 1/10th dose of induction if not adequate, till loss of verbal contact. Intervention2: PROPOFOL WITH SCOLINE: Propofol- Dose-2.5 mg/kg… |
| Registration date | Feb 14, 2022 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: